2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow BTRX-335140: new trials by email Literature Review of BTRX-335140 trials Research Report on BTRX-335140
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| To Evaluate the Effects of NMRA-335140 on Symptoms of Major Depression in Participants With Bipolar II Disorder. NMRA-335140 80 mg, Placebo - Major Depressive Episode Associated With Bipolar II Disorder | Phase 2 | Completed | Neumora Therapeutics, Inc. | 18 | 2024-05-13 | 2026-03-30 |
| Study in Major Depressive Disorder With NMRA-335140 (BTRX-335140) vs Placebo NMRA-335140, Placebo - Major Depressive Disorder | Phase 2 | Completed | Neumora Therapeutics, Inc. | 204 | 2020-01-03 | 2025-05-29 |
Bipolar Disorder (1) · Depressive Disorder, Major (1)
Neumora Therapeutics, Inc. (2)
United States (2)